Medroxyprogesterone acetate (depo‐provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinoma

M. Steven Piver*, Joseph J. Barlow, John R. Lurain, Leslie E. Blumenson

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

79 Scopus citations

Fingerprint

Dive into the research topics of 'Medroxyprogesterone acetate (depo‐provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinoma'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

INIS

Neuroscience

Veterinary Science and Veterinary Medicine